Catch the stories you don't want to miss 👀 and get 25% off STAT+

Get 25% off an annual STAT+ subscription and read more of our award-winning journalism.

My Account    STAT+ Ten must-read stories from the last month Get behind the paywall to these these stories and more and take 25% off your first year of STAT+ by using code LOYAL25. DRUG ENFORCEMENT ADMINISTRATION 1   The inside story of how Lykos' MDMA research went awry By Olivia Goldhill MICHAEL CONROY/AP 2   Elevance PBM's president out as customers complain of prescription chaos By Brittany Trang TIM BOYLE/GETTY IMAGES 3   Millions fewer people may need statins, a new study suggests. But guidelines have yet to agree By Elizabeth Cooney Want even more of STAT? Subscribe to STAT+ for exclusive discounts on data-driven reports, virtual and live events, and access to subscriber-only newsletters. We'll help you stay ahead. SUBSCRIBE NOW More Top Stories 4   A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals By Adam Feuerstein 5   Top FDA official Peter Marks overruled staff, review team to approve Sarepta gene therapy By Jason Mast and Matthew Herper 6   Will Geron be acquired? The long-short view By Adam Feuerstein 7   Which hospital systems will join Kaiser's Risant next? By Bob Herman 8   FDA approves Sarepta's Duchenne gene therapy for nearly all patients By Jason Mast 9   A new discovery about carbon dioxide is challenging decades-old ventilation doctrine By Megan Molteni 10   Novartis is flashing warning signs about the fate of its newly acquired myelofibrosis drug By Adam Feuerstein read more STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us